Cell line authentication and characterization test is a combination of processes designed to verify the identity of strains and to check that it is free from microbial and other cell line contaminants. It is a type of biological safety testing. Cell line authentication is an important step to ensure the reproducibility and integrity of biomedical research. The contaminants in cell cultures are bacteria, viruses, fungi, and contamination from other cell lines of different or same species. Contaminants alter the physiology and properties of cells, compromising the results of experiments.
The American Type Culture Collection (ATCC), a nonprofit organization that collects, stores, and distributes cell lines, standard reference microorganisms, and other materials for research and development, and other recognized cell banks, regularly performs authentication and quality control tests for various cell line samples used in the industry. Several methods are available for cell line authentication such as HLA typing, karyotyping, and isoenzyme analysis. However, currently the best method to authenticate human cell line is short tandem repeat (STR) profiling. It is a reliable, less expensive, and simple method that provides identification to the level of individual cell line.
Request For Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=36029
Rise in geriatric population and increase in incidence of chronic diseases are projected to drive the global cell line authentication and characterization tests market. Additionally, growing need for accurate qualitative and quantitative analysis of cell line is anticipated to propel the market during the forecast period from 2017 to 2015. Moreover, increase in cell line production for production of biopharmaceuticals is expected to augment the market. Furthermore, rise in research for identification of novel biomolecule for drug discovery, growing awareness among people, and government regulations in different regions boost the growth of the global cell line authentication and characterization tests market. Growing research in the field of genetic engineering is also likely to drive the market during the forecast period. High adoption rate of new technologies and rapidly growing health care industry are the major drivers of the global cell line authentication and characterization tests market.
The global cell line authentication and characterization tests market can be segmented based on application and region. In terms of application, the market can be categorized into cellular therapy, gene therapy, stem cell products, tissue & tissue products, blood & blood products, and vaccines & therapeutics,
Request For Custom Research – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=36029
Geographically, the global cell line authentication and characterization tests market can be segmented into Asia Pacific, Latin America, Europe, North America, and Middle East & Africa. North America held the largest market share in 2016 due to increased government regulations, technological advancements, and growing awareness among people. Europe held the second largest market share in 2016 due to mandatory biological safety testing for identification of contaminants for biologics used in human. The market in Asia Pacific is projected to be driven by the growing biopharmaceutical industry, new product launches, increase in health care expenditure, and rise in research activities.
The cell line authentication and characterization tests market in Latin America is anticipated to grow during the forecast period owing to factors such as increase in research, surge in incidence of pandemic and endemic diseases, rise in per capita income of the middle class, technological advancements, and government regulations. The cell line authentication and characterization tests market in Middle East & Africa is projected to grow during the forecast period driven by increase in technological upgrades and enhanced participation of governments to promote academic research to improve these technologies.
Request For Covid19 Impact Analysis Across Industries And Markets @ https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=36029
Key players operating in the global cell line authentication and characterization tests market include Thermo Fisher Scientific, Inc., Charles River Laboratories International, Inc., Lonza, Takara Bio USA, Inc., GE Healthcare, and QIAGEN.
Read Our Trending Press Release Below
- https://www.prnewswire.co.uk/news-releases/global-vascular-access-devices-market-to-grow-with-advancements-in-cardiovascular-treatment-lines-says-tmr-823600417.html
- https://www.prnewswire.com/news-releases/wide-range-of-applications-bringing-growth-opportunities-for-tissue-processing-systems-market-tmr-301209993.html
According to the report, the global medical education market was valued at ~US$ 32 Bn in 2019 and is projected to expand at a CAGR of ~5% from 2020 to 2030.
The market for distance training is quite small; those attempting to gain certification through distance learning are unlikely to gain complete knowledge.
This is a globally accepted view.
In terms of type of training, the global medical education market has been classified into cardiothoracic training, neurology training, orthopedic training, oral & maxillofacial training, pediatric training, radiology training, laboratory training, and others.Read Report Overview - https://www.transparencymarketresearch.com/medical-education-market.htmlBased on mode of training, the global market has been categorized into on-campus, distance, and online.
In terms of education providers, the global medical education market has been divided into school of medicine, government/military organization, hospitals, insurance & co., non-profit organization, publishing or education company, molecular genetic methods, and others.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=517Based on application, the global medical education market has been split into cardiovascular diseases, diabetes, cancer, hypertension, infections, bronchitis, dehydration, sleep disorder, weight management & fitness monitoring, and others.
The cardiovascular diseases segment held significant share of the global medical education market in 2019.
The presence of few leading players is what makes the Asia Pacific butene-1 market increasingly consolidated and fairly consolidated, notes Transparency Market Research (TMR).
The competitive landscape features a low level of threat from the entry of new players.
Prominent names include ONGC Petro additions Limited, PetroChina Company Limited, China National Petroleum Corporation, China Petrochemical Corporation, and Petrochemical Corporation of Singapore (Private) Limited.The Asia Pacific butene-1 market is projected to expand at a CAGR of during the forecast period of 2016–2026.
This is attributed to the vast uptake of the compound in the production of high density polyethylene (HDPE) and linear low density polyethylene (LLDPE) products in the region.Geography-wise, China has emerged to the fore with its robust supplier base and it held the share of more than 65% in the regional market.
Substantial production capabilities in the country will help it retain its dominance throughout the assessment period.Vast Uptake in Producing Plastic Packaging Materials to Accentuate Regional MarketThe Asia Pacific butene-1 market has witnessed steady expansion over the past few years, riding on the back of the rising demand for plastic packaging materials.
The bold strides being made by the packaging industry in the region in the recent years has fueled the demand for butene-1.
Global Rare Neurological Disease Treatment Market – OverviewRare neurological diseases are vastly underdiagnosed and most of them go untreated.
It is expected that the global rare neurological disease treatment market will have a great potential in the coming years of the forecast period ranging from 2020 to 2030.
Increasing awareness about these diseases, advancing healthcare and neurobiological technologies, and fast track approvals of new treatment methods are some of the key factors that will help in pushing up the growth of the global market.Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=79898Global Rare Neurological Disease Treatment Market – Notable DevelopmentsIn terms of competitive landscape of the global neurological disease treatment market, there are several key players operating in the market space.
This makes the competitive landscape a highly fragmented one.
The companies in the market are mainly focusing on developing new and innovative therapeutics to diagnose and treat these neurological diseases.The market consists of a few significant players who dominate the market.
Some of the leading market players include CSL Ltd, Kedrion Biopharma Inc., US WorldMeds LLC (Solstice Neurosciences LLC), Merz Pharma GmbH & Co. KGaA, Aquestive Therapeutics Inc., Bayer AG, Pfizer Inc., Novartis AG, Merck & Co. Inc. (EMD Serono Inc.), and Jazz Pharmaceuticals PLC.Request For Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR_id=79898Global Rare Neurological Disease Treatment Market – Driver and RestraintsThere are several factors that are responsible for the overall development of the global rare neurological disease treatment market.
Transparent Market Research (TMR) reflects the competitive landscape of the global pharmaceutical chemical spread across the globe.
New strategies are expected to be introduced to penetrate into the market.
Rising population and low mortality rate seems to be the reason for lucrative growth in the healthcare sector.
Swell in the geriatric population calls for increase in healthcare facilities.
Global pharmaceutical chemical market is projected to be flourishing in coming years due to rise in demand for drugs for non-communicable diseases.
However, developments in all the fields of healthcare facilities and rising geriatric population is projected to inflate the global pharmaceutical chemical market.Request for covid19 impact analysis –https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=37685Disease Oriented Treatment to Push GrowthVarious therapy based applications are expected to increase the demand for global pharmaceutical chemical market.
